Showing results (21-30 of 42) with videos related to
Sort By:
Pageof 5
Journal of Translational Medicine|April 18, 2025
GPX2 inhibition enhances antitumor efficacy of lenvatinib via promoting immunogenic cell death in hepatocellular carcinomaYingzheng Tan, Lei Yang, Tao Xu, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 18, 2019
Is lymph node dissection necessary for resectable intrahepatic cholangiocarcinoma? A systematic review and meta-analysisRui Zhou, Dihan Lu, Wenda Li, et al.Journal of Hepatocellular Carcinoma|January 17, 2023
Identification of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and Responsiveness to Immunotherapy in Hepatocellular CarcinomaQingbin Wang, Bingkun Wang, Xiaowu Ma, et al.Journal of Hepatocellular Carcinoma|February 25, 2022
SLC39A1 Overexpression is Associated with Immune Infiltration in Hepatocellular Carcinoma and Promotes Its Malignant ProgressionXiaowu Ma, Hongkai Zhuang, Qingbin Wang, et al.Oncology Research|March 4, 2017
TRAF4 Regulates Migration, Invasion, and Epithelial-Mesenchymal Transition via PI3K/AKT Signaling in Hepatocellular CarcinomaKairui Liu, Xiaolin Wu, Xian Zang, et al.Gynecologic Oncology|October 20, 2018
SOX2 regulates radioresistance in cervical cancer via the hedgehog signaling pathwayChunxian Huang, Huaiwu Lu, Jing Li, et al.Apoptosis : an International Journal on Programmed Cell Death|November 10, 2024
Lenvatinib inhibits cholangiocarcinoma progression by targeting the FGF19/PI3K/AKT signaling pathwayYingcheng Wei, Lei Yang, Chenwei Tang, et al.Ebiomedicine|December 31, 2018
TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinomaWenliang Tan, Xuan Luo, Wenda Li, et al.Cell Death & Disease|May 17, 2022
CircLIFR suppresses hepatocellular carcinoma progression by sponging miR-624-5p and inactivating the GSK-3β/β-catenin signaling pathwayLei Yang, Wenliang Tan, Yingcheng Wei, et al.Pageof 5